Globus Medical Inc Stock Prediction and Forecast [GMED]

AI-generated source summary

This analysis of Globus Medical (GMED) stock, recorded on November 7th, 2025, presents a Hold recommendation with a score of 0.0, noting an average daily gain of 2.54% over the past 17 days. The stock broke an upward trend but potential support is found at $65.35. The three-month trend suggests a potential 4.28% increase, yet a 12-month analysis indicates a -29.76% change, with a price range between $28.63 and $58.93. Friday saw a gain of 35.94% closing at $83.89, however there is over valuation for the trading on Monday 10th.Recent insider trading showed a significant buying volume compared to selling volume Insider trading power is at 33.45. The analysis advises a stop-loss at $81.16, while a 14-day RSI stands at 87. A buy signal emerged 31 days prior and analysts assigned a buy rating.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   08 Nov 2025, 04:37 UTC

   The analyst published the original source item.

2. First prediction resolved

   08 Jan 2026, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   08 Jan 2026, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:11 UTC

   Tahlil Plus began monitoring the extracted predictions.